Hsp70 response to 5-fluorouracil treatment in human colon cancer cell lines

International Journal of Colorectal Disease

Volumn 22, Issue 10, 2007, Pages 1201-1208

  Grivicich, Ivana ^a   Regner, Andréa ^a   Zanoni, Caroline ^a   Correa, Larissa Procópio ^a   Jotz, Geraldo Pereira ^a   Henriques, João Antônio Pêgas ^b   Schwartsmann, Gilberto ^c   da Rocha, Adriana Brondani ^a  

^a UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c South American Office for Anticancer Drug Development SOAD   (Brazil)

Author keywords

5 Fluorouracil; Apoptosis; Hsp70; Humancolon cancer cell lines

Indexed keywords

FLUOROURACIL; HEAT SHOCK PROTEIN 70;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL PROTECTION; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SENSITIVITY ANALYSIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROURACIL; HSP70 HEAT-SHOCK PROTEINS; HUMANS; TIME FACTORS;

EID: 34548190284     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-007-0307-x     Document Type: Article

References (62)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
2. Van Cutsen E, Verslpe C (2002) Integration of new cytotoxic agents in the management of advanced colorectal cancer: Where are we now and where do we go? Educational Book 38th Ann Meet ASCO, pp 240-247
3. Skibber JM, Minsky BD, Hoff P (2001) Cancer of the colon. In: DeVita VT, Hellman S, Rosenberg AS (eds) Cancer: Principles and practice of oncology. Williams and Wilkins, Philadelphia, pp 1216-1271
4. Schmoll HJ, Buchele T, Grothey A, Dempke W (1999) Where do we stand with 5-fluorouracil? Semin Oncol 26:589-605
5. Mayer RJ (2000) Moving beyond fluorouracil for colorectal cancer. N Engl J Med 343:63-964
6. Grem JL (2000) 5-fluorouracil: Forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs 18:299-313
7. Peters GJ, van der Wilt CL, van Triest B, Codacci-Pisanelli G, Johnston PG, van Groeningen CJ, Pinedo HM (1995) Thymidylate synthase and drug resistance. Eur J Cancer 31A:1299-1305
8. Mader RM, Muller M, Steger GG (1998) Resistance to 5-fluorouracil. Gen Pharmacol 31:661-666
9. Nita ME, Nagawa H, Tominaga O, Tsuno N, Fujii S, Sasaki S, Fu CG, Takenoue T, Tsuruo T, Muto T (1998) 5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteins. Br J Cancer 78:986-992
10. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T (2002) Resistance of colon cancer cells to long-term 5-Fluorouracil exposure is correlated to the relative level of bcl-2 and bcl-xl in addition to bax and p53 status. Int J Cancer 98:498-504
11. Lowe SW, Lin AW (2000) Apoptosis in cancer. Carcinogenesis 21:485-495
12. Rupnarain C, Dlamini Z, Naicker S, Bhoola K (2004) Colon cancer: genomics and apoptotic events. Biol Chem 385:449-464
13. Gorlick R, Bertino JR (1999) Drug resistance in colon cancer. Semin Oncol 26:606-611
14. Lazaris AC, Kavantzas NG, Zorzos HS, Tsavaris NV, Davaris PS (2002) Markers of drug resistance in relapsing colon cancer. J Cancer Res Clin Oncol 128:114-118
15. Jäättelä M (1999) Heat shock proteins as cellular lifeguards. Ann Med 31:261-271
16. Kregel KC (2002) Heat shock proteins: Modifying factors in physiological stress responses and acquired thermotolerance. J Appl Physiol 92:2177-2186
17. Rokutan K, Hirakawa T, Teshima S, Nakano Y, Miyoshi M, Kawai T, Konda E, Morinaga H, Nikawa T, Kishi K (1998) Implications of heat shock/stress proteins for medicine and disease. J Med Investig 44:137-146
18. Xanthoudakis S, Nicholson DW (2000) Heat-shock proteins as death determinants. Nat Cell Biol 2:E163-E165
19. Takayama S, Reed JC, Homma S (2003) Heat-shock proteins as regulators of apoptosis. Oncogene 22:9041-9047
20. Sarto C, Binz P, Mocarelli P (2000) Heat shock proteins in human cancer. Electrophoresis 21:1218-1226
21. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G (2001) Heat shock proteins: Endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 286:433-442
22. Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H (2005) Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma. Anticancer Res 25:2749-2755
23. Rashmi R, Kumar S, Karunagaran D (2004) Ectopic expression of Hsp70 confers resistance and silencing its expression sensitizes human colon cancer cells to curcumin-induced apoptosis. Carcinogenesis 25:179-187
24. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 13:1107-1112
25. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
26. Swe M, Sit KH (2000) Z-VAD-fmk and DEVD-cho induced late mitosis arrest and apoptotic expressions. Apoptosis 5:29-36
27. Bradford MM (1978) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
28. Kitchens ME, Forsthoefel AM, Barbour KW, Spencer HT, Berger FG (1999) Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stability. Mol Pharmacol 56:1063-1070
29. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C, Lesuffleur T (2002) Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 98:498-504
30. Guichard S, Hennebelle I, Bugat R, Canal P (1998) Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line. Biochem Pharmacol 55:667-676
31. Espinosa A, Marchal JA, Aranega A, Gallo MA, Aiello S, Campos J (2005) Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation. Farmaco 60:91-97
32. Gmeiner WH, Trump E, Wei C (2004) Enhanced DNA-directed effects of FdUMP[10] compared to 5FU. Nucleosides Nucleotides Nucleic Acids 23:401-410
33. Grivicich I, Regner A, da Rocha AB, Grass LB, Alves PA, Kayser GB, Schwartsmann G, Henriques JA (2005) Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines. Oncol Res 15:385-392
34. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11:121-139
35. Mesner P, Budihardjo I, Kaufman SH (1997) Chemotherapy-induced apoptosis. Adv Pharmacol 41:461-499
36. Backus HH, Wouters D, Ferreira CG, van Houten VM, Brakenhoff RH, Pinedo HM, Peters GJ (2003) Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines. Eur J Cancer 39:1310-1317
37. Kaufmann SH, Earnshaw WC (2000) Induction of apoptosis by cancer chemotherapy. Exp Cell Res 256:42-49
38. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochromec/ Apaf-1/caspase-9 apoptosome. Nature 6907:634-637
39. Konishi T, Sasaki S, Watanabe T, Kitayama J, Nagawa H (2006) Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL. Oncogene 25:3160-3169
40. Boyer J, McLean EG, Aroori S, Wilson P, McCulla A, Carey PD, Longley DB, Johnston PG (2004) Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res 10:2158-2167
41. Moller P, Koretz K, Leithauser F, Bruderlein S, Henne C, Quentmeier A, Krammer PH (1994) Expression of APO-1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epithelium. Int J Cancer 57:371-377
42. Houghton JA, Harwood FG, Tillman DM (1997) Thymineless death in colon carcinoma cells is mediated via Fas signaling. Proc Natl Academic Sci USA 94:8144-8149
43. Eisold S, Linnebacher M, Ryschich E, Antolovic D, Hinz U, Klar E, Schmidt J (2004) The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines. World J Gastroenterol 10:3583-3589
44. Lenz HJ, Hayashi K, Salonga D, Danenberg KD, Danenberg PV, Metzger R, Banerjee D, Bertino JR, Groshen S, Leichman LP, Leichman CG (1998) p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival. Clin Cancer Res 4:1243-1250
45. Cascinu S, Catalano V, Aschele C, Barni S, Debernardis D, Gallo L, Bandelloni R, Staccioli MP, Baldelli AM, Brenna A, Valenti A, Muretto P, Catalano G (2000) Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil-leucovorin combination. Ann Oncol 11:1053-1116
46. Jäättelä M (1995) Overexpression of Hsp70 confers tumorigenicity to mouse fibrosarcoma cells. Int J Cancer 60:689-693
47. Hwang TS, Han HS, Choi HK, Lee YJ, Kim Y, Han M, Park Y (2003) Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J Gastroenterol Hepatol 18:690-700
48. Gurbuxani S, Bruey JM, Fromentin A, Larmonier N, Parcelier A, Jaattela M, Martin F, Solary E, Garrido C (2001) Selective depletion of inducible HSP70 enhances immunogenicity of rat colon cancer cells. Oncogene 20:7478-7485
49. Seo JS, Park YM, Kim CW, Jang JJ, Kim SH, Lee WH (1996) T cell lymphoma in transgenic mice expressing the human hsp70 gene. Biochem Biophys Res Commun 218:582-587
50. Volloch V, Rits S (1999) A natural extracellular factor that induces Hsp72, inhibits apoptosis, and restores stress resistance in aged human cells. Exp Cell Res 253:483-492
51. Elpek GÖ, Karaveli S, Simsek T, Keles N, Aksoy NH (2003) Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumor of the ovaries. APMIS 111:523-530
52. Liu FF, Miller N, Levin W, Zanke B, Cooper B, Henry M, Sherar MD, Pintilie M, Hunt JW, Hill RP (1996) The potential role of Hsp70 as an indicator of response to radiation and hyperthermia treatments for recurrent breast cancer. Int J Hyperthermia 12:197-208
53. Nylandsted J, Wick W, Hirt UA, Brand K, Rohde M, Leist M, Weller M, Jaattela M (2002) Eradication of glioblastoma, and colon carcinoma xenografts by Hsp70 depletion. Cancer Res 62:7139-7142
54. Lebret T, Watson RW, Fitzpatrick JM (2003) Heat shock proteins: Their role in urological tumors. J Urol 169:338-346
55. Gabai VL, Meriin AB, Yaglom JA, Volloch VZ, Sherman MY (1998) Role of Hsp70 in regulation of stress-kinase JNK: Implications in apoptosis and aging. FEBS Lett 438:1-4
56. Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M (1998) Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 17:6124-6134
57. Zylicz M, King FW, Wawrzynow A (2001) Hsp70 interactions with the p53 tumour suppressor protein. EMBO J 20:4634-4638
58. Jolly C, Morimoto RI (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92:1564-1572
59. Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, Mcguire WL (1992) Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52:3648-3654
60. Mehlen P, Schulze-Osthoff K, Arrigo AP (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 271:16510-16514
61. Caraglia M, Marra M, Budillon A, Meo G, Ricciardiello F, Bismuto E, Brachelente G, Francini G, Giordano A, Correale P, Abbruzzese A (2005) Chemotherapy regimen GOLF induces apoptosis in colon cancer cells through multi-chaperone complex inactivation and increased Raf-1 ubiquitin-dependent degradation. Cancer Biol Ther 4:1159-1167
62. Correale P, Cerretani D, Cleirici M, Cozzi C, Bruni G, Pozzessere D, Petrioli R, Marsili S, Messinese S, Sabatino M, Giorgi G, Francini G (2000) Gemcitabine (dFdC), 5-fluorouracil (5FU) and Folinic Acid (FA) in the treatment of patients with gastroenteric carcinomas: A clinical and pharmacological study. Second National Congress of Medical Oncology. Ann Oncol 11(Suppl 2):67